8-K
Current Report
ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0000930413-09-001530
Material agreement · Delisting notice · Unregistered share sale · Executive or director change · Bylaws or fiscal year change · Regulation FD disclosure
- Item 1.01 Entry into a material definitive agreement
- Item 3.01 Notice of delisting or failure to meet a listing standard
- Item 3.02 Unregistered sales of equity securities
- Item 5.02 Departure or appointment of directors or officers
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
- Item 7.01 Regulation FD disclosure
From the SEC's structured data for this filing
Loading c56987_8k.htm…